Features, News -

USADA announces one-year suspension for masters world record holder

Supported by

USADA has announced a one-year ban for Barbara Gicquel, 80, after she tested positive for a prohibited substance at masters track nationals last year.

Gicquel tested positive for metabolites of methyltestosterone in August of 2019 after setting a 75-79 age-group record in the time trial.

Gicquel apparently applied for a Therapeutic Use Exemption (TUE) retroactively for a medication containing methyltestosterone that she had been using since 2005, but she did not list the medication on forms for the anti-doping control at the event despite listing various other medications and supplements.

According to USADA, Gicquel’s TUE application “was denied because the documentation she submitted did not establish that she had a medical condition that required the use of methyltestosterone and indicated that her use of the medication was likely to provide an additional athletic performance benefit beyond a return to a normal state of health.”

USADA’s press release announcing the news notes that Gicquel became aware that her medication contained the substance in 2015. Notably, she was tested multiple times between 2016 and 2019 as she competed at masters events in that period but did not test positive until last August.

She accepted a one-year sanction from USADA and, following review of the case of an independent arbitrator, she was stripped of results from August 29, 2015, the date she learned that her medication contained the substance.

The post USADA announces one-year suspension for masters world record holder appeared first on CyclingTips.


Tags